John Mazzola. [Image courtesy of Vicarious Surgical]

约翰·马佐拉。[图片由Vicarious Surgical提供]

Vicarious Surgical

替代手术公司

(NYSE:RBOT) announced today that John Mazzola, its chief operating officer (COO), plans to retire.

（纽约证券交易所代码：RBOT）今天宣布，其首席运营官（COO）约翰·马佐拉计划退休。

Mazzola’s retirement goes into effect on April 1, 2025. He plans to continue to serve as COO until that date, at which time he hands his responsibilities over to company president Randy Clark.

马佐拉的退休将于2025年4月1日生效。他计划继续担任首席运营官直到那一天，届时他将把职责移交给公司总裁兰迪·克拉克。

In May 2023,

2023年5月，

Mazzola received a promotion to the post of COO

马佐拉被提升为首席运营官。

at the Waltham, Massachusetts-based surgical robot developer. He originally

在马萨诸塞州沃尔瑟姆的外科机器人开发公司。他最初

joined the company in March 2022

2022年3月加入公司

as SVP of operations. Mazzola spent nearly 40 years in the medical device industry. That included involvement in more than 25 medical device product launches.

作为运营高级副总裁，马佐拉在医疗设备行业工作了近40年。其间参与了25个以上的医疗设备产品发布。

Before joining Vicarious, Mazzola spent 13 years in senior executive roles and product development leadership positions at BD. That included serving as VP of operations for BD’s surgery business.

在加入Vicarious之前，马佐拉在BD公司担任了13年的高级执行官和产品开发领导职务，其中包括担任BD外科手术业务的运营副总裁。

“On behalf of the entire organization, I want to express our sincere gratitude to John for his exceptional leadership and dedication over the past few years,” said Adam Sachs, co-founder and CEO. “John has been instrumental in developing and streamlining our corporate manufacturing processes, enhancing our product quality control, and strengthening our supply chain resilience; as a result, Vicarious Surgical is well-positioned for its next chapter as we prepare for our upcoming first clinical use cases and pivotal trial.

“代表整个组织，我要对约翰过去几年的卓越领导和奉献表示衷心的感谢，”联合创始人兼首席执行官亚当·萨克斯说。“约翰在开发和优化我们的企业制造流程、提升产品质量控制以及增强供应链弹性方面发挥了重要作用；因此，当我们准备迎接即将到来的首次临床应用和关键试验时，Vicarious Surgical已为下一阶段的发展做好了充分准备。”

We are deeply grateful for his contributions and wish him a happy and fulfilling retirement.”.

我们对他做出的贡献深表感谢，并祝他退休后幸福美满。"

Mazzola’s retirement announcement makes him the second member of the Vicarious C-suite to depart the company in recent months. In December, the company

马佐拉的退休声明使他成为近几个月来维卡里奥C级管理层中第二位离开公司的成员。去年12月，该公司

announced that CFO William Kelly planned to leave

宣布首席财务官威廉·凯利计划离职

to pursue other career opportunities.

追求其他职业机会。

Analysts at the time questioned the departure, asking why the CFO would leave “at this point.” The company develops its Version 1.0 (V1.0) surgical robot aimed at increasing the efficiency of surgical procedures, but has hit some snags over the past couple of years.

当时，分析师对这次离职提出了质疑，询问为什么首席财务官会在这个时候离开。该公司开发了旨在提高手术效率的1.0版（V1.0）手术机器人，但在过去几年中遇到了一些障碍。

Vicarious previously eyed first-in-human trials midway through this year, but it

Vicarious 之前预计在今年年中进行首次人体试验，但

pushed V1.0’s timeline back in November 2023

将V1.0的时间表推迟到2023年11月

. In March, the company

。三月，公司

maintained its timeline

保持了时间表

to have V1.0 ready for an FDA submission by

准备好V1.0以提交给FDA

early- to mid-fiscal 2026

2026财年初期至中期

, which remains unchanged even with movement atop the company.

，即使在公司内部调动，这一情况依然保持不变。